Wellgistics Health, Inc.
WGRX
$0.63
$0.0814.86%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 478.87% | 17,148.17% | 17,106.05% | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 478.87% | 17,148.17% | 17,106.05% | -- | -- |
| Cost of Revenue | 503.87% | 71,598.94% | -- | -- | -- |
| Gross Profit | 416.41% | 114,265.38% | -- | -- | -- |
| SG&A Expenses | 1,944.70% | 1,528.89% | 1,183.69% | 135.99% | -- |
| Depreciation & Amortization | 553.77% | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1,057.46% | 2,870.91% | 2,145.88% | 742.68% | -- |
| Operating Income | -1,985.89% | -1,517.80% | -1,165.34% | -113.33% | -- |
| Income Before Tax | -2,059.46% | -1,618.01% | -1,217.69% | -136.77% | -- |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -2,059.46% | -1,618.01% | -1,217.69% | -136.77% | -- |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2,059.46% | -1,618.01% | -1,217.69% | -136.77% | -- |
| EBIT | -1,985.89% | -1,517.80% | -1,165.34% | -113.33% | -- |
| EBITDA | -3,616.03% | -6,879.17% | -- | -- | -- |
| EPS Basic | -1,563.94% | -1,365.25% | -1,554.98% | -220.09% | -- |
| Normalized Basic EPS | -1,543.24% | -1,368.58% | -1,559.03% | -221.01% | -- |
| EPS Diluted | -1,685.21% | -1,524.53% | -1,757.36% | -431.15% | -- |
| Normalized Diluted EPS | -1,543.24% | -1,368.58% | -1,559.03% | -221.01% | -- |
| Average Basic Shares Outstanding | 28.90% | 17.11% | 45.35% | 109.98% | -- |
| Average Diluted Shares Outstanding | 28.90% | 17.11% | 45.35% | 109.98% | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |